Visionary Holdings Navigates Fiscal Crossroads: Revenue Declines Amidst Strategic Pivot to Health and Aesthetics
Toronto, ON – January 20, 2026 – Visionary Holdings Inc. (Nasdaq: GV) has released its audited financial statements for the fiscal year ended March 31, 2025, signaling a period of significant strategic reorientation. While the company’s Form 20-F filing with the SEC is still pending, the released financials reveal a substantial year-over-year revenue contraction, offset by early commercial progress in its burgeoning health-focused ventures.
The company reported total revenue of $5.04 million for FY2025, a sharp decline of 46.2% compared to the previous year. This downturn was primarily attributed to a contraction in its real estate leasing segment, which brought in $2.80 million, and shifts within the education policy landscape impacting its education services revenue of $1.18 million. However, the nascent health management, anti-aging, and premium medical aesthetics businesses collectively generated $1.06 million, constituting approximately 21.1% of the total revenue. This contribution from emerging sectors highlights the initial traction of Visionary Holdings’ strategic pivot.
Financially, the company recorded a net loss of $15.75 million. This figure includes approximately $4.70 million in asset impairment charges, reflective of the ongoing transformation and restructuring efforts. Despite the overall loss, management pointed to an improvement in the gross margin to 28.0%, with the education services segment demonstrating notable operational stability with a gross margin of 64.4%. Furthermore, operating cash outflows saw a reduction, decreasing to $2.97 million from $4.10 million in the prior fiscal year, indicating some progress in operational efficiency.
Total assets stood at $63.63 million as of March 31, 2025. However, the company is grappling with a significant challenge: negative working capital of approximately $54.50 million. This liquidity pressure, coupled with existing loan defaults, has prompted Visionary Holdings to actively pursue equity financing and engage in negotiations with creditors for debt restructuring and extensions, with some creditors having already agreed to temporary relief. The company acknowledges the ongoing liquidity and financing pressures and is continuously evaluating measures to bolster its financial standing.
The strategic transformation underway aims to reposition Visionary Holdings as a diversified platform centered on health management, anti-aging, and premium medical aesthetics. The company is exploring service-oriented offerings in health management, including gastrointestinal health solutions, leveraging a model that combines platform development, strategic partnerships, and direct service delivery. Initial market testing and early commercialization efforts are reportedly underway in Asia.
In the premium medical aesthetics space, Visionary Holdings is focusing on service-driven solutions, aligning with market demand in Asia and drawing upon North American medical expertise. Strategic collaborations have been established with entities such as Jiangsu Yike Regenerative Medicine Technology Co., Ltd. and Anhui Weikang Kangling Medical Technology Co., Ltd. These partnerships are intended to provide access to proprietary technologies and competitive product resources, facilitating the expansion of a global premium medical aesthetics service network.
Meanwhile, the company’s AI education business, offering OSSD programs and vocational training through a hybrid online-offline model, has remained relatively stable. Collaborations with Canadian public institutions continue to support international students.
Commenting on the fiscal year, CEO Xiyong Hou stated, “Fiscal year 2025 marked a critical phase in which the Company’s strategic transformation progressed from planning toward tangible execution. The initial revenue contributions generated by emerging businesses during the reporting period validated the practical feasibility of our transition toward health management, anti-aging, and premium medical aesthetics, and provided a foundation for subsequent development.”
Looking ahead, Visionary Holdings plans to concentrate on high-potential segments within premium medical aesthetics and cellular rejuvenation. The company anticipates driving this segment towards meaningful revenue scale within the next two years, contingent on market dynamics, regulatory environments, and execution progress. Simultaneously, significant emphasis will be placed on strengthening corporate governance, enhancing financial and compliance capabilities, and reinforcing internal controls to ensure sustainable growth and long-term shareholder value.
The company’s outlook also includes further optimizing its AI education ecosystem and expanding its marketing efforts in key Asian markets to ensure business stability and cash flow generation. A continued focus on recruiting experienced finance and compliance professionals, alongside enhanced training and audit committee operations, is intended to improve financial reporting quality and operational transparency.
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/16365.html
